Watch our symposium on cloud-first and generative AI technology
- By Philips
- March 03 2025
- Duration 58: 44
- Featuring AWS, Policlinico Gemelli
Check out the panel discussion hosted by Philips and hear about leveraging public cloud and generative AI technology to empower the next generation of radiology. We explore how radiology informatics solutions benefit from secure, compliant cloud technology and can automatically scale to support vast amounts of imaging data. We also discuss how AI/ML and generative AI in healthcare can serve as a radiologist’s assistant to help enhance diagnostic speed and quality while supporting patient outcomes – all thanks to the public cloud.
At-a-glance:
- Reinventing medical imaging: cloud-first, AI-first and Generative AI in Healthcare
- A modern PACS as the cornerstone of radiology departments and their evolving needs
- Impact of cloud and AI on Research and Clinical Imaging
- Panel discussion
Featuring
Razvan Ionasec
PhD, MBA
Chief Technology Officer Healthcare EMEA
Amazon Web Services (AWS), Munich, Bavaria, Germany
Read more
Razvan Ionasec, PhD, MBA, is the technical leader for healthcare at Amazon Web Services in EMEA. His work focuses on helping healthcare customers solve business problems by leveraging technology. He holds 30+ patents and has published 70+ international peer-reviewed publications.
Shez Partovi
Chief Innovation & Strategy Officer and Chief Business Leader of Enterprise Informatics, Philips
Philips, Cambridge, MA
Madhuri Sebastian
Radiology Informatics Business Leader
Philips, United States
Copy this URLto share this story with your professional network
Footnotes
- Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129.
- Gotberg M, et al. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. Int J Cardiol 2021 1;344:54-59.
- 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96. Japan guidelines
- Jeremias A et al. Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary Intervention: The DEFINE PCI Study. JACC Cardiovasc Interv. 2019 Oct 28;12(20):1991-2001.
- Patel M., et al. 1-Year outcomes of blinded physiological assessment of residual ischemia after successful PCI. JACC Cardiol Interv. 2022;15(1):52-61.
- FDA 510k (#K173860). The iFR modality is intended to be used in conjunction with currently marketed Philips pressure wires. In the coronary anatomy, the iFR modality has a diagnostic cut-point of 0.89 which represents an ischemic threshold and can reliably guide revascularization decisions during diagnostic catheterization procedure.
- Gotberg M. et al. iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI. Late-breaking clinical Trial presentation at TCT on November 4, 2021.
Disclaimer
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Results in other cases may vary.